All News about Immunovant Inc![]() ![]() ![]() Via Benzinga
![]() ![]() ![]()
Recap: Immunovant Q3 Earnings
February 12, 2024
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Analyst Ratings for Immunovant
December 01, 2023
Via Benzinga
![]()
Where Immunovant Stands With Analysts
November 15, 2023
Via Benzinga
![]()
Recap: Immunovant Q2 Earnings
November 09, 2023
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Micron Posts Upbeat Sales, Joins Calliditas Therapeutics And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
December 21, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
![]()
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |